Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

Dr. Tareq I. Nassar, MD, MBBS

Contact

210-567-4843

nassart@uthscsa.edu

Departments & Divisions

Tareq I. Nassar, MD, MBBS

Associate Professor/Clinical

Nephrology Fellowship-Program Director

Medical Director UHS Renal Clinics and Dialysis West Clinic

Integrity, diligence, perseverance, and discipline are the core principles that define me as a person. "The best interest of the patient is the only interest to be considered"; this eloquent dictum from Dr. William J. Mayo has shaped my work ethics as a physician. As such, I believe that a competent physician must be entirely devoted – in heart, mind, and spirit – to the care of his patients. A physician who is empowered with the knowledge and experience can make a difference in his patients‘ lives and gain their trust. Medicine is a life-long learning process. To become a great teacher, one should nurture his love of learning. Scott Hayden described this exquisitely in his powerful quote "Teachers have three loves: love of learning, love of learners, and the love of bringing the first two loves together."

  • Professional Background

    Education

    • 2010 - MBBS - Medicine - Jordan University of Science and Technology

    Training

    • 2016 - Clinical Fellowship - Nephrology - UTHSA
    • 2014 - Residency - Internal Medicine - UTHSA

    Highlights

    06/2019 Robert Kunau Award for Excellence in Teaching: I was nominated by Nephrology Fellows at UTHSA to receive this award.
    07/2018 5-Star Rating Dialysis West: Under my leadership, dialysis west has achieved and maintained a 5-star rating under the Dialysis Facility Compare (DFC) program by the CMS. This is the highest rating a dialysis facility can receive from CMS and reflects the provision of care that is "well above average" when compared to other dialysis facilities nationwide.

  • Instruction & Training

    • 02/2020-present, MED14170 Internal Medicine, UTHSA
    • 10/2017-present, PHAR4003 Clinical Pharmacology , UTHSA
    • 03/2017-present, CIRC5015 Renal and Male Reproductive, UTHSA

  • Research & Grants

    Grants

    01/2020-Present Principal Investigator, PRECISION: Multi-center, Blinded, Randomized, Parallel-group, Phase 3 Study With Aprocitentan in Subjects With Resistant Hypertension (RHT) (Sponsor: Idorsia)
    12/2019-Present Principal Investigator, DISCOVER CKD: An observational study collecting real-world data on patients with chronic kidney disease to assess: early treatment experience, treatment patterns, treatment effectiveness, patient outcomes and patient quality of life through prospective and retrospective data capture. (Sponsor: AstraZeneca AB)
    12/2019-Present Principal Investigator, A Phase 2a Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of MEDI3506 (Anti-IL 33) in Subjects With Diabetic Kidney Disease. (Sponsor: AstraZeneca)
    10/2019-Present Sub Investigator, FLOW: Effect of semaglutide versus placebo on the progression of renal impairment in subjects with type 2 diabetes and chronic kidney disease. [IRB Protocol: HSC20190216H].

  • Service

    School

    07/2019- Present Physician Assistant Students,Renal Clinic Rotation, UTHSA. We started to have physician assistant students rotate with us in the renal clinic from July to
    December. I supervise 1-2 students every one to two weeks. They see patients on their own and present the case to me. I focus on their presentation and documentation skills. I also discuss some essential topics in nephrology, i.e., hypertension management, chronic kidney disease classification, hyponatremia, etc.

    Institutional

    11/2019-Present: Outpatient Nephrology Hemodialysis Rotation, UTHSA.
    07/2018-Present: Internal Medicine Primary Care Track Renal Clinic, UTHSA
    11/2016-Present: Outpatient Nephrology Clinic Rotation, UTHSA
    11/2016-Present: Inpatient Nephrology Service

  • Publications

      Chandan Takkar, MD., Tareq I. Nassar, MD., and Wajeh Y. Qunibi, MD, FACP.. An evaluation of sodium zircnium cyclosilicate as a treatment option for hyperkalemia. Manuscript submitted. Currently, in peer review process. Expert Opinion on Pharmacotherapy 2020 Feb.

      Tareq I. Nassar, and Wajeh Y. Qunibi. AKI Associated with Acute Pancreatitis Clinical Journal of the American Society of Nephrology 2019 Jul;14(7):1106-1115.

      El Kour, M, Nassar T, Sehgal R. JAW CLAUDICATION, VISION LOSS AND HIGH ESR: ALWAYS TEMPORAL ARTERITIS? 2014. (Journal of Hospital Medicine; vol. 2, no. 408).

  • Clinical

    07/2020 ACEI, ARB and COVID-19: The Knowns, The Unknowns and The Facts!, Internal Medicine Grand Rounds, UTHSA (Sole Presenter)
    05/2020 Kidney Self-Assessment Program (KSAP) Questions Review, Nephrology Division Conference, UTHSA, MR, San Antonio, TX (Sole Presenter)
    02/2020 Hyponatremia Management, Texas Academy of Physician Assistants Annual Conference, Texas Academy of Physician Assistants, Texas Academy of Physician Assistants, San Antonio, TX (Invited Speaker)
    01/2020 On the mechanism by which chloride corrects metabolic alkalosis in man, Nephrology Division Journal Club, Nephrology Division, UTHSA